Storys zum Thema Medikament

Poda Lifestyle and Wellness Ltd.

Landmark Clinical Study Shows Heated Tobacco Products May Reduce the Health Risks of Cigarette Smoking

Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC: PODAF) is pleased to announce that a landmark new clinical study has shown that the health risks of cigarette smoking may be reduced in smokers who completely switch to using tobacco-heating ...

CartiHeal (2009) Ltd.

CartiHeal Announces Pivotal Study Results Demonstrate Agili-C(TM) Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects

Kfar Saba, Israel (ots/PRNewswire) - According to a Two-Year Randomized and Controlled Multinational IDE Study CartiHeal Ltd, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthrough Device Designation by the FDA last ...

RadiAction Medical Ltd.

The new patents highlight Radiaction's superior innovation in radiation protection

Tel Aviv, Israel (ots/PRNewswire) - Radiaction Medical Ltd. ("Radication"), a medical device company, announced today that it was granted additional patents in the US and Japan, protecting key technological developments of its radiation shielding device. Radiaction, is revolutionizing radiation protection by providing full-body shielding to all medical personnel during ...

Norgine; US WorldMeds

Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand

Amsterdam, Netherlands and Louisville, Ky. (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), a Kentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by which Norgine will register and commercialise ...

The Untold Story

The Untold Story Releases Zhang Boli's Short Documentary on the Battle Against the Pandemic

News Direct

ZOE Study Reveals Eating a Plant Rich Diet Reduces Risk of Developing COVID-19 and Going to the Hospital

Schweizerischer Nationalfonds / Fonds national suisse

Clinical research: patients and the public have their say

Bern (ots) - The Swiss National Science Foundation has been funding clinical studies on under-researched topics in medicine since 2016. In a first, it successfully involved representatives of patients and the public in evaluating applications. The aim of the SNSF's Investigator Initiated Clinical Trials (IICT) programme is to answer medical questions that are important to society but not a priority for industry. This ...

Servier; Nymirum

Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

Paris (ots/PRNewswire) - Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced today that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases. Under the collaboration ...

GSK Consumer Healthcare

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

Nyon, Switzerland (ots/PRNewswire) - New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. Today sees the launch of Let's treat it right, a major new health education campaign designed to bridge a knowledge gap ...

Almirall; MC2 Therapeutics

Almirall and MC2 Therapeutics announce completion of decentralized procedure in Europe for the topical treatment of mild to moderate psoriasis vulgaris in adults

Barcelona, Spain and Copenhagen, Denmark (ots/PRNewswire) - - The successful completion of a decentralized procedure is the final step before national marketing authorizations can be granted by the European countries - MC2 Therapeutics has granted Almirall exclusive European rights to commercialize this topical ...

Tianjin Haihe Media Group

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

Wuhan (ots) - In September, 2020, Zhang Boli was awarded with the national honorary title, "the People's Hero," for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to commend people who have made outstanding contribution in the fight, and carry forward their dedication and other noble qualities. This short ...

Tianjin Haihe Media Group

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

Tianjin, China (ots) - In September, 2020, Zhang Boli was awarded with the national honorary title, "the People's Hero," for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to commend people who have made outstanding contribution in the fight, and carry forward their dedication and other noble qualities. This ...

News Direct

3

Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access

Pierre Fabre; EORTC

European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients

Brussels and Castres, France (ots/PRNewswire) - Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients ...

Abcam; Pionyr

Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients

South San Francisco, Calif. and Cambridge, England (ots/PRNewswire) - - The partnership will support the progression of PY314, the first of Pionyr's Myeloid Tuning(TM) antibodies to enter the clinic - Pionyr will use Abcam's EPR20243 clone to evaluate TREM2 levels in tissue samples for potential future development ...

Valcon Medical A/S

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations

Copenhagen (ots/PRNewswire) - Valcon Medical A/S ("Valcon Medical" or the "Company"), Denmark's leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021. Under the DKMA ...

Epredia

Epredia And Aiforia Announce Partnership For Global Distribution Of AI-powered Pathology Software

Portsmouth, N.h. (ots/PRNewswire) - Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for ...

Norgine GmbH

Norgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.

Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and Beijing Podconley Pharmaceutical Technology & Development Co., Ltd. (Beijing Podconley), today announced an exclusive distribution agreement by which Beijing Podconley will commercialise Norgine's product ...

Shycocan

TNO research shows effectiveness of corona cannon

Rijswijk, Netherlands (ots/PRNewswire) - Addition due to incomplete information in the press release as sent on 4 June 2021 Analyses carried out by TNO in a BSL-3 laboratory cabinet showed that the corona gun had achieved a 94.9% reduction in the Covid -19 virus after 15 minutes. In the laboratory set-up, the (live) virus was located on stainless steel plates at 85 cm from the device. Earlier, the Dutch scientific ...

Fundação Bial

BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June

Porto, Portugal (ots/PRNewswire) - The second edition of the BIAL Award in Biomedicine is currently underway. Worth three hundred thousand Euros, this prize is intended to reward a work with exceptional quality results and scientific relevance published in the last ten years in the broad field of biomedicine. The winner will be chosen by an independent and ...

Biobeat

Biobeat Launches Wearable Continuous Ambulatory Blood Pressure Monitoring (ABPM) Device

Petah Tikva, Israel (ots/PRNewswire) - New Clinical Data Supports Use of Biobeat ABPM Cuffless-Monitor as Reliable and Accurate Solution for Out-of-Clinic Blood Pressure Monitoring Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today the launch of its new wearable and continuous ambulatory blood pressure ...

Roche Diabetes Care

Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone

Novo Nordisk

Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities

Bagsværd, Denmark (ots/PRNewswire) - Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with obesity being treated with semaglutide 2.4 mg. The trial showed that treatment with once-weekly semaglutide 2.4 mg led to ...

Roche Diabetes Care

Roche collaborates with Lilly to support people with diabetes on insulin pen therapy

Basel, Switzerland (ots/PRNewswire) - - Roche and Lilly will integrate data from Lilly's connected insulin pen solution into the mySugr app in several countries. - Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals. - By ...